Skip to main content
KTTA logo

KTTA · Pasithea Therapeutics Corp.

Track KTTA — free
$0.56 -0.01 (-1.92%) At close · Sep 1
Market Cap
$18.81M
Shares
33.41M

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2025-05-14 Tiago Reis Marques 960
Showing 1–1 of 1 filings
Key facts CIK 1841330 CUSIP 70261F202 13F (30d) 31 filings 31 filers Visit website Investor relations